https://practicaldermatology.com/issues/january-february-2025/how-to-ensure-people-first-content/32978/daily0.7https://practicaldermatology.com/issues/january-february-2025/in-depth-from-the-science-of-skincare-summit/32979/daily0.7https://practicaldermatology.com/topics/acne-rosacea/Key-Successful-Teen-Acne-Treatment/32981/daily0.7https://practicaldermatology.com/series/dermwire-tv/nemluvio-gains-two-major-indications-in-europe/32982/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/hs-tips-and-lizards/35858/daily0.7https://practicaldermatology.com/series/dermwire-tv/study-examines-socioeconomic-status-and-hs-diagnosis/35859/daily0.7https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/breakthroughs-in-alopecia-areata-treatment/33019/daily0.7https://practicaldermatology.com/conferences/masterclasses-in-dermatology-2025/masterclasses-in-dermatology-the-importance-of-interdisciplinary-teaching/33021/daily0.7https://practicaldermatology.com/series/c-suite-chats/skin-coverage-as-a-medical-benefit/35559/daily0.7https://practicaldermatology.com/series/dermwire-tv/long-term-bimzelx-data-presented/35563/daily0.7https://practicaldermatology.com/issues/april-2025/origins-of-ad-recent-advances/35586/daily0.7https://practicaldermatology.com/issues/april-2025/the-biosimilar-revolution-a-look-at-the-potential-impact/35596/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/the-importance-and-utility-of-gep-testing/35597/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/when-and-how-to-use-ancillary-testing/35598/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-for-cutaneous-squamous-cell-carcinoma/35599/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/evaluating-gep-test-options/35600/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/gep-testing-in-surgical-oncology/35601/daily0.7https://practicaldermatology.com/issues/april-2025/10-tips-for-managing-hidradenitis-suppurativa/35602/daily0.7https://practicaldermatology.com/series/updates-in-skin-cancer/using-gep-test-results-to-manage-patients/35603/daily0.7https://practicaldermatology.com/issues/april-2025/are-you-sure/35604/daily0.7https://practicaldermatology.com/issues/april-2025/the-impact-of-clascoterone-topical-cream-1/35605/daily0.7https://practicaldermatology.com/issues/april-2025/the-importance-of-diversity-in-clinical-trials/35606/daily0.7https://practicaldermatology.com/series/dermwire-tv/nemluvio-shows-efficacy-in-ad/36134/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/all-things-psoriasis-with-dr-april-armstrong/36135/daily0.7https://practicaldermatology.com/series/c-suite-chats/ai-for-patient-education-and-more/36239/daily0.7https://practicaldermatology.com/cme/dermatology/pruritus-in-pn-and-ad-challenge-how-you-manage-itch/36304/daily0.7https://practicaldermatology.com/cme/dermatology/data-driving-recent-guideline-updates-in-neoadjuvant-therapy-for-resectable-melanoma/36322/daily0.7https://practicaldermatology.com/cme/dermatology/clinical-implications-of-neoadjuvant-therapy-guideline-updates-in-resectable-melanoma/36323/daily0.7https://practicaldermatology.com/cme/dermatology/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iibiic-melanoma/36324/daily0.7https://practicaldermatology.com/cme/dermatology/efficacy-and-safety-outcomes-for-adjuvant-immunotherapy-driving-guideline-recommendations-for-stage-iiiiv-melanoma/36325/daily0.7https://practicaldermatology.com/cme/dermatology/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-stage-iii-melanoma/36326/daily0.7https://practicaldermatology.com/cme/dermatology/data-driving-preferred-guideline-recommendations-in-first-line-therapy-for-metastatic-melanoma/36327/daily0.7https://practicaldermatology.com/cme/dermatology/implementing-guideline-concordant-care-for-a-patient-with-newly-diagnosed-braf-mutant-stage-iv-melanoma/36328/daily0.7https://practicaldermatology.com/cme/dermatology/clinical-data-prompting-guideline-updates-for-subcutaneous-icis-in-melanoma/36329/daily0.7https://practicaldermatology.com/cme/dermatology/emerging-and-practice-changing-data-in-immunotherapy-strategies-for-melanoma/36330/daily0.7https://practicaldermatology.com/cme/dermatology/insights-from-global-key-opinion-leaders-on-regional-regulatory-and-guideline-nuances-to-optimize-melanoma-management/36331/daily0.7https://practicaldermatology.com/series/dermwire-tv/research-highlights-disparities-in-ad-care/36472/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/advocacy-and-research/36479/daily0.7https://practicaldermatology.com/series/updates-atopic-dermatitis/evaluating-lebrikizumab-in-pigmented-skin/36490/daily0.7https://practicaldermatology.com/issues/july-2025/clean-beauty/36492/daily0.7https://practicaldermatology.com/issues/july-2025/fighting-for-coverage/36503/daily0.7https://practicaldermatology.com/issues/july-2025/we-are-all-from-somewhere/36504/daily0.7https://practicaldermatology.com/issues/july-2025/bpo-alternative-acne-options/36505/daily0.7https://practicaldermatology.com/issues/july-2025/comorbidities-in-alopecia-areata/36507/daily0.7https://practicaldermatology.com/issues/july-2025/psoriasis-update-current-state-pipeline-and-more/36509/daily0.7https://practicaldermatology.com/issues/july-2025/patient-growth-made-easy-smart-strategies-for-mature-cosmetic-practices/36510/daily0.7https://practicaldermatology.com/issues/july-2025/saving-for-the-high-cost-of-college-new-rule-offers-additional-options/36511/daily0.7https://practicaldermatology.com/issues/july-2025/fine-particulate-matter-and-eczema/36512/daily0.7https://practicaldermatology.com/issues/july-2025/on-purpose-pediatrics-and-pioneering-care-a-conversation-with-dr-lisa-swanson/36514/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwiretv-pharma-partnership-boosts-spesolimab-plus-more/36519/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-remembering-dr-robert-sidbury/36520/daily0.7https://practicaldermatology.com/topics/skin-cancer-photoprotection/making-melanoma-diagnosis-and-treatment-more-predictable/37102/daily0.7https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwiretv-dermarite-issues-recall-for-several-hand-soaps/37113/daily0.7https://practicaldermatology.com/series/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/diagnostic-approach-for-prurigo-nodularis/37137/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37139/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/unmet-needs-in-atopic-dermatitis-management/37145/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37148/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37152/daily0.7https://practicaldermatology.com/conferences/scale-2025/fractional-lasers-for-nmsc-and-more/35876/daily0.7https://practicaldermatology.com/conferences/scale-2025/medical-dermatology-highlights/35889/daily0.7https://practicaldermatology.com/conferences/scale-2025/therapeutic-advances-and-fighting-for-authorizations/35890/daily0.7https://practicaldermatology.com/conferences/scale-2025/procedural-management-for-hs/35891/daily0.7https://practicaldermatology.com/conferences/scale-2025/rosacea-treatment-options-and-strategies/35893/daily0.7https://practicaldermatology.com/conferences/scale-2025/updates-on-psoriasis-biologics/35894/daily0.7https://practicaldermatology.com/conferences/scale-2025/rosacea-comorbidities-and-skincare-with-energy-based-devices/35895/daily0.7https://practicaldermatology.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/daily0.7https://practicaldermatology.com/conferences/scale-2025/nail-disease-and-jak-inhibitor-safety/35897/daily0.7https://practicaldermatology.com/conferences/scale-2025/advances-in-hair-loss-treatments/35899/daily0.7https://practicaldermatology.com/issues/may-june-2025/a-taste-of-my-own-medicine/35914/daily0.7https://practicaldermatology.com/issues/may-june-2025/harnessing-ai-for-dermatology-residents/35915/daily0.7https://practicaldermatology.com/issues/may-june-2025/melanoma-updates-epidemiology-diagnostics-and-treatment/35917/daily0.7https://practicaldermatology.com/issues/may-june-2025/the-value-of-radiation-as-an-option-for-bcc-and-scc/35919/daily0.7https://practicaldermatology.com/issues/may-june-2025/vitiligo-update-pathogenesis-therapies-and-integrative-approaches/35920/daily0.7https://practicaldermatology.com/issues/may-june-2025/mechanisms-for-food-allergy-initiation-by-skin-pre-disposed-to-atopic-dermatitis/35922/daily0.7https://practicaldermatology.com/issues/may-june-2025/leadership-without-authority-influencers-of-culture-in-your-practice/35924/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-phase-3-data-on-roflumilast-for-ad-pso/35925/daily0.7https://practicaldermatology.com/series/c-suite-chats/targeting-senescent-cells/35960/daily0.7https://practicaldermatology.com/series/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/daily0.7https://practicaldermatology.com/series/updates-atopic-dermatitis/clinical-data-on-switching-to-upadacitinib/36534/daily0.7https://practicaldermatology.com/series/dermwire-tv/DWTV-Extra-DermLink-Scholars-Founder-Dr-Kelly-Frasier/36554/daily0.7https://practicaldermatology.com/series/c-suite-chats/fda-approval-for-delgocitinib/36650/daily0.7https://practicaldermatology.com/issues/august-2025/new-hope-jak-inhibitors-alopecia/36693/daily0.7https://practicaldermatology.com/issues/august-2025/female-hair/36697/daily0.7https://practicaldermatology.com/issues/august-2025/differentiating-gpp-from-plaque-psoriasis-for-targeted-therapy/36700/daily0.7https://practicaldermatology.com/issues/august-2025/scurvy-following-gastric-bypass/36701/daily0.7https://practicaldermatology.com/issues/august-2025/comorbidities-in-vitiligo/36702/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-gpp-awareness-day/36704/daily0.7https://practicaldermatology.com/issues/august-2025/transitioning-from-academia-to-private-practice/36705/daily0.7https://practicaldermatology.com/issues/august-2025/psoriasis-treatment-in-2025-more-options-better-outcomes/36706/daily0.7https://practicaldermatology.com/issues/august-2025/choosing-or-evaluating-your-advisors-3-mistakes-to-avoid/36707/daily0.7https://practicaldermatology.com/issues/august-2025/marketing-leading-technologies-that-support-your-team/36708/daily0.7https://practicaldermatology.com/issues/august-2025/recurrent-generalized-pustular-psoriasis/36711/daily0.7https://practicaldermatology.com/issues/august-2025/remembering-dr-robert-sidbury/36712/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/addressing-the-psychologic-impact-of-atopic-dermatitis-on-pediatric-patients/37174/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/food-allergies-and-atopic-dermatitis-in-the-pediatric-population/37175/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37178/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37180/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37181/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/37182/daily0.7https://practicaldermatology.com/series/nemluvio-peer-network/how-nemluvio-works/37226/daily0.7https://practicaldermatology.com/series/nemluvio-peer-network/clinical-conversations-a-conversation-with-dr-angela-lamb-a-dermatologist-and-professor-in-new-york-new-york/37237/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwiretv-deucravacitinib-maintains-efficacy-in-pso-at-3-years/37249/daily0.7https://practicaldermatology.com/topics/psoriasis/dwtv-extra-consensus-statements-on-genital-psoriasis/37269/daily0.7https://practicaldermatology.com/series/dermwire-tv/clinical-data-on-a-new-therapeutic-for-ad/37270/daily0.7https://practicaldermatology.com/cme/dermatology/test-your-skills-and-learn-from-experts-on-il-13-inhibitors-in-moderate-to-severe-atopic-dermatitis/37624/daily0.7https://practicaldermatology.com/issues/september-2025/what-more-do-you-want-from-me-reflections-on-mentorship-dermatology-and-moving-forward/37625/daily0.7https://practicaldermatology.com/issues/september-2025/staphylococcus-aureus-colonization/37626/daily0.7https://practicaldermatology.com/issues/september-2025/cutaneous-manifestations-associated-with-nemolizumab/37628/daily0.7https://practicaldermatology.com/issues/september-2025/preparing-for-private-equity-benefits-and-drawbacks/37629/daily0.7https://practicaldermatology.com/issues/september-2025/the-benefits-of-private-practice-a-qa-with-joel-schlessinger-md-faad/37630/daily0.7https://practicaldermatology.com/issues/september-2025/mergers-and-acquisitions-in-derm-and-aesthetics-market-outlook/37631/daily0.7https://practicaldermatology.com/issues/september-2025/the-esop-model-an-alternative-to-pe-for-dermatology-practices/37637/daily0.7https://practicaldermatology.com/issues/september-2025/dermatology-recruitment-in-the-age-of-private-equity/37638/daily0.7https://practicaldermatology.com/issues/september-2025/first-reported-case-of-red-face-response-to-tralokinumab-in-the-united-states/37639/daily0.7https://practicaldermatology.com/issues/september-2025/from-training-to-transformation-how-leaders-get-the-most-out-of-educating-their-team/37640/daily0.7https://practicaldermatology.com/issues/september-2025/busy-by-design-plans-how-to-use-downtime-to-drive-revenue-and-make-uptime-smoother-for-your-team/37641/daily0.7https://practicaldermatology.com/issues/september-2025/dr-dianne-davis-on-mentorship-lasers-skin-of-color-and-more/37643/daily0.7https://practicaldermatology.com/series/c-suite-chats/regenerative-treatments-in-dermatology/37707/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/antimicrobial-resistance-and-psoriasis-remission/39042/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-rocatinlimab-trials/39044/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/neuroimmune-parallels-in-atopic-dermatitis-and-prurigo-nodularis/39667/daily0.7https://practicaldermatology.com/cme/dermatology/psoriasis-and-obesity-going-pound-for-pound-on-comprehensive-patient-centered-management/39671/daily0.7https://practicaldermatology.com/issues/october-2025/practical-dermatology-october-2025-page-turner-format/39843/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-dianne-davis/39879/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-sheila-barbarino/39880/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-socioeconomic-neighborhood-status-linked-with-hs-severity-plus-more/39881/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/program-name/39883/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/educating-nps-and-pas/39884/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/psoriasis-challenges-and-alopecia-areata-advances/39885/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-psoriasis-advocacy/39890/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37153/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37154/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/treatments-for-prurigo-nodularis/37156/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/the-future-of-customized-treatments-within-the-atopic-dermatitis-pipeline/37165/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/controlling-the-itch-in-prurigo-nodularis/37169/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/derm-hub/37170/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-vitiligo-ingenuity-award/37869/daily0.7https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-combining-dupilumab-and-omalizumab/37872/daily0.7https://practicaldermatology.com/series/dermwire-tv/biologics-preferred-after-mace-in-pso-plus-more/37882/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/the-battle-of-biostimulators-plla-vs-hyperdilute-caha/39250/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-with-dr-tina-bhutani/39251/daily0.7https://practicaldermatology.com/series/dermwire-tv/increased-aps-risk-for-psoriasis-patients-plus-more/39299/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/beyond-the-flare-choosing-the-right-systemic-in-moderate-to-severe-atopic-dermatitis/39728/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwiretv-fda-clears-roflumilast-guselkumab-for-pediatric-populations-plus-more/39732/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39735/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39736/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39737/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39738/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/pdrn-regenerative-medicine-update/39739/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39741/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39742/daily0.7https://practicaldermatology.com/conferences/science-of-skin-summit-2025/tbd/39743/daily0.7https://practicaldermatology.com/issues/october-2025/finding-joy-in-dermatology/39751/daily0.7https://practicaldermatology.com/issues/october-2025/remaking-ourselves-aesthetic-medicine-that-is-regenerative/39752/daily0.7https://practicaldermatology.com/issues/october-2025/evaluating-pdgf-with-a-2910-nm-laser-in-skin-of-color/39753/daily0.7https://practicaldermatology.com/issues/october-2025/legalities-of-injecting-pdgf-off-label-or-out-of-bounds/39754/daily0.7https://practicaldermatology.com/issues/october-2025/upadacitinib-and-cardiovascular-events-in-ad/39755/daily0.7https://practicaldermatology.com/issues/october-2025/comorbidities-in-atopic-dermatitis/39756/daily0.7https://practicaldermatology.com/issues/october-2025/apocrine-hidrocystoma-of-the-axilla-an-illustrative-case-and-literature-review/39757/daily0.7https://practicaldermatology.com/issues/october-2025/a-guide-to-building-lifelong-patient-loyalty/39758/daily0.7https://practicaldermatology.com/issues/october-2025/injectable-aesthetic-treatments-for-immediate-and-regenerative-results/39759/daily0.7https://practicaldermatology.com/issues/october-2025/global-aesthetics-and-regenerative-medicine/39760/daily0.7https://practicaldermatology.com/issues/october-2025/navigating-the-latest-therapeutic-options/39762/daily0.7https://practicaldermatology.com/issues/october-2025/clinical-insights-and-emerging-therapeutic-options-for-chronic-hand-eczema/39763/daily0.7https://practicaldermatology.com/issues/october-2025/targeting-the-ox40-pathway/39764/daily0.7https://practicaldermatology.com/issues/october-2025/in-the-pipeline-clinical-trials/39765/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/the-benefits-of-balneotherapy-for-atopic-dermatitis/39776/daily0.7https://practicaldermatology.com/series/c-suite-chats/nonsurgical-skin-tightening-and-facelifts/39781/daily0.7https://practicaldermatology.com/series/c-suite-chats/improving-care-options-for-ctcl/48714/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-topical-caffeine-for-hair-growth-tapinarof-for-pediatric-ad/48734/daily0.7https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-heritage-of-pdgf/48868/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/glp-1ras-and-the-dermatologist/48885/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/who-is-the-man-at-the-back/48887/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/effectiveness-of-early-moisturizer-use-in-atopic-dermatitis-prevention/48889/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/48890/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/48891/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/colloidal-oat-wash-helps-infants-with-ad-prone-skin/48896/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-current-roles-in-medicine/48897/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/pipeline-and-potential-roles-for-glp-1ras-in-dermatology/48898/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/the-role-of-glp-1ras-in-treating-inflammatory-dermatologic-diseases/48899/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/glp-1-receptor-agonists-and-the-aesthetic-patient/48900/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/rejuvenating-your-practices-online-presence/48901/daily0.7https://practicaldermatology.com/series/c-suite-chats/effector-cell-response-inhibitors/48960/daily0.7https://practicaldermatology.com/issues/novemberdecember-2025/practical-dermatology-novdec-2025-page-turner-format/48997/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-ruxolitinib-cream-15-effective-for-ad-improvement-stapokibart-shows-promise/49101/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/3-years-of-real-world-data-for-an-ad-biologic/50769/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/implications-of-the-overlap-between-csu-and-atopic-dermatitis/50850/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/strategizing-to-capitalize-on-emollients/50865/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/analyzing-the-overlap-between-atopic-dermatitis-prurigo-nodularis-and-chronic-spontaneous-urticaria/50877/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/a-closer-look-at-ox40-pathway-modulation/50890/daily0.7https://practicaldermatology.com/series/dermwire-tv/dermwire-tv-2025-in-review/54093/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/balneotherapy-continued-a-future-in-us-dermatology/54116/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-skin-and-scalp-health/54147/daily0.7https://practicaldermatology.com/series/c-suite-chats/innovation-in-androgenetic-alopecia/54265/daily0.7https://practicaldermatology.com/series/c-suite-chats/nonsurgical-skin-tightening-and-facelifts/54266/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-spotlight-on-leadership/54267/daily0.7https://practicaldermatology.com/topics/psoriasis/using-glp-1s-for-psoriasis-and-hidradenitis-suppurativa/54269/daily0.7https://practicaldermatology.com/topics/atopic-dermatitis/biological-and-environmental-factors-in-facial-eczema/54270/daily0.7https://practicaldermatology.com/issues/januaryfebruary-2026/the-ninth-inning-of-fomo/54451/daily0.7https://practicaldermatology.com/issues/januaryfebruary-2026/a-busy-time-in-the-field/54452/daily0.7https://practicaldermatology.com/topics/psoriasis/comorbidities-in-psoriasis/54453/daily0.7https://practicaldermatology.com/issues/januaryfebruary-2026/practical-dermatology-janfeb-2026-page-turner-format/54455/daily0.7https://practicaldermatology.com/topics/practice-management/how-to-bring-your-practice-exponential-revenue-growth/54456/daily0.7https://practicaldermatology.com/series/type-ii-inflammation-journal-club/reducing-atopic-march-risk-in-pediatric-atopic-dermatitis/54821/daily0.7https://practicaldermatology.com/topics/rare-disease/the-hidradenitis-suppurativa-therapeutic-pipeline/54824/daily0.7https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/how-skinspan-goes-beyond-anti-aging/54825/daily0.7https://practicaldermatology.com/columns/atopic-dermatitis-essentials/precision-medicine-for-ad/54826/daily0.7https://practicaldermatology.com/series/skin-minute/safe-step-act-update/54846/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/the-war-zone-private-practice/54847/daily0.7https://practicaldermatology.com/topics/pigmentary-disorders/a-case-study-in-treating-carotenoderma/56301/daily0.7https://practicaldermatology.com/topics/practice-management/the-role-of-hcc-coding-in-dermatology/56303/daily0.7https://practicaldermatology.com/series/c-suite-chats/coding-for-superficial-radiation-therapy/56364/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-raising-awareness-of-gpp/56366/daily0.7https://practicaldermatology.com/columns/skin-cancer-essentials/finding-the-perfect-sunscreen-for-patients-with-skin-of-color/56391/daily0.7https://practicaldermatology.com/series/skin-minute/heather-woolery-lloyd-md-skin-minute/56411/daily0.7https://practicaldermatology.com/issues/march-2026/practical-dermatology-march-2026-page-turner-format/56412/daily0.7https://practicaldermatology.com/series/il-17-journal-club/understanding-the-effect-of-targeting-il-17af-in-psoriatic-arthritis/56663/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/how-do-barrier-dysfunction-proteins-interact-with-immune-dysregulation-to-sustain-ad/56736/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-2/56870/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-3/56871/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-4/56872/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-5/56873/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-6/56874/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-7/56875/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-8/56876/daily0.7https://practicaldermatology.com/series/skin-minute/integument-ole-study/56899/daily0.7https://practicaldermatology.com/issues/april-2026/practical-dermatology-2026-page-turner-format/56923/daily0.7https://practicaldermatology.com/topics/acne-rosacea/dont-just-see-red-see-your-head/56925/daily0.7https://practicaldermatology.com/topics/acne-rosacea/advancing-care-in-acne-and-rosacea/56926/daily0.7https://practicaldermatology.com/topics/acne-rosacea/debating-isotretinoin-considerations/56927/daily0.7https://practicaldermatology.com/topics/acne-rosacea/lasers-and-light-for-acne-and-rosacea/56928/daily0.7https://practicaldermatology.com/topics/acne-rosacea/a-practical-update-on-benzoyl-peroxide/56929/daily0.7https://practicaldermatology.com/topics/acne-rosacea/special-considerations-for-acne-in-skin-of-color/56930/daily0.7https://practicaldermatology.com/topics/other-dermatology/stressed-skin-and-how-dermatologists-can-help/56931/daily0.7https://practicaldermatology.com/topics/skin-of-color/lost-in-translation-psychodermatology-through-an-interpreter/56932/daily0.7https://practicaldermatology.com/topics/practice-management/the-real-cost-of-credit-cards-to-your-practice/56933/daily0.7https://practicaldermatology.com/topics/practice-management/marketing-new-investments-in-good-times-and-bad/56934/daily0.7https://practicaldermatology.com/series/practical-dermatology-podcasts/the-science-of-skin-hidradenitis-suppurativa/56945/daily0.7https://practicaldermatology.com/series/c-suite-chats/the-evolving-needs-of-the-modern-patient/39900/daily0.7https://practicaldermatology.com/topics/skin-cancer-photoprotection/from-diagnosis-to-prognosis-using-mypath-melanoma-and-decisiondx-melanoma-to-help-guide-patient-management-decisions/39944/daily0.7https://practicaldermatology.com/topics/rare-disease/should-children-and-adolescents-be-screened-for-primary-hyperhidrosis/39946/daily0.7https://practicaldermatology.com/cme/dermatology/when-topicals-fail-the-new-ipc-consensus-every-clinician-should-know/39967/daily0.7https://practicaldermatology.com/topics/rare-disease/can-prescription-hyperhidrosis-treatments-help-mitigate-symptoms/39997/daily0.7https://practicaldermatology.com/series/il-17-journal-club/mental-health-implications-in-psoriasis/48771/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/how-does-chronic-ad-histopathology-evolve-from-spongiosis-dominant-lesions-to-lichenified-fibrotic-plaques/48772/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/contributing-factors-to-persistent-or-adult-onset-atopic-dermatitis/48773/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/the-emergence-of-targeted-therapies-for-prurigo-nodularis/48775/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/the-effect-of-the-microbiome/48776/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/analyzing-il-31-and-the-benefits-of-blocking-it/48777/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/differentiating-atopic-dermatitis-from-psoriasis-and-ctcl/48778/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/improving-adherence-to-topical-regimens/48780/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/a-guidelines-based-recommendations-algorithm-for-atopic-dermatitis/48781/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/tbd/48782/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/where-does-phototherapy-still-fit-in/48783/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/tbd/48784/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/non-biologics-in-treatment-and-management-of-prurigo-nodularis/48785/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/sequencing-therapies-for-long-term-control-of-atopic-dermatitis/48786/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/differentiating-prurigo-nodularis-lesions/48787/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/dysregulation-of-type-2-immune-pathway/48788/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/sleep-disturbances-and-psychological-burden-of-prurigo-nodularis/48790/daily0.7https://practicaldermatology.com/series/dermatology-hub-neuroimmune-network/il-31s-role-in-prurigo-nodularis/48804/daily0.7https://practicaldermatology.com/series/il-17-journal-club/mechanisms-of-action-for-il-17-inhibition-in-treating-psoriasis-and-hidradenitis-suppurativa/48808/daily0.7https://practicaldermatology.com/series/il-17-journal-club/treatment-approaches-for-psoriatic-arthritis/48809/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/balancing-a-busy-career-mentorship-session-with-dr-peter-lio/48812/daily0.7https://practicaldermatology.com/youngmd-connect/on-demand-virtual-sessions/ask-me-anything-mentorship-session-dr-natasha-mesinkovska-on-academia-alopecia-areata-and-more/48814/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-podcast/ensuring-equity-for-your-patients/54335/daily0.7https://practicaldermatology.com/topics/atopic-dermatitis/an-overview-of-topical-ththerapies-for-managing-pediatric-ad/54375/daily0.7https://practicaldermatology.com/topics/rare-disease/how-epidermolysis-bullosa-treatments-went-from-blisters-to-breakthroughs/54391/daily0.7https://practicaldermatology.com/cme/dermatology/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/daily0.7https://practicaldermatology.com/issues/januaryfebruary-2026/non-annular-granuloma-annulare-reports-and-review/54446/daily0.7https://practicaldermatology.com/topics/rare-disease/the-dos-and-donts-of-managing-pediatric-hidradenitis-suppurativa/54450/daily0.7https://practicaldermatology.com/series/skin-minute/evaluating-roflumilast-for-seborrheic-dermatitis/54610/daily0.7https://practicaldermatology.com/series/dermwire-tv/innovation-in-androgenetic-alopecia/54611/daily0.7https://practicaldermatology.com/series/c-suite-chats/advocating-for-hs-patients/54617/daily0.7https://practicaldermatology.com/series/the-practical-dermatology-roundtable-adjuvant-skin-cleansing-and-moisturizing/practical-dermatology-roundtable-the-role-of-adjuvant-skin-cleansing-and-moisturizing-in-treating-psoriasis-and-other-inflammatory-diseases-ch-1/54619/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-data-on-oral-therapeutics-for-psoriasis/54643/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/new-allergens-causing-contact-dermatitis/54644/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/turning-acne-treatment-strategies-upside-down/54645/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/strategies-for-treating-patients-on-glp-1-receptor-agonists-and-more/54646/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/wound-closure-after-mohs-surgery/54648/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/rosacea-new-and-old-medications-isotretinoin-and-flushing/54654/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/clinical-questions-about-isotretinoin-and-more/54661/daily0.7https://practicaldermatology.com/conferences/maui-derm-hawaii-2026/tips-and-tricks-for-prescribing-biologics-for-pediatric-patients/54662/daily0.7https://practicaldermatology.com/series/skin-minute/connections-for-the-future-of-dermatology/54688/daily0.7https://practicaldermatology.com/series/c-suite-chats/commitment-to-clinical-evidence-in-regenerative-aesthetics/54693/daily0.7https://practicaldermatology.com/topics/rare-disease/pediatric-hidradenitis-suppurativa/56417/daily0.7https://practicaldermatology.com/series/nemluvio-peer-network/clinical-conversations-video-with-dr-scott-boswell/56420/daily0.7https://practicaldermatology.com/series/nemluvio-peer-network/clinical-conversations-discover-dr-j-scott-boswells-perspective-on-redefining-pn-and-ad-through-a-neuroimmune-lens/56421/daily0.7https://practicaldermatology.com/series/c-suite-chats/the-case-for-prioritizing-patient-reacquisition/56424/daily0.7https://practicaldermatology.com/topics/editorial/the-pull-of-mental-escapism/56427/daily0.7https://practicaldermatology.com/topics/rare-disease/a-new-era-in-hidradenitis-suppurativa-care/56428/daily0.7https://practicaldermatology.com/topics/rare-disease/10-procedural-tips-for-hidradenitis-suppurativa/56430/daily0.7https://practicaldermatology.com/topics/rare-disease/topical-treatments-for-hidradenitis-suppurativa/56433/daily0.7https://practicaldermatology.com/topics/skin-cancer-photoprotection/comparing-sunscreen-for-skin-of-color-print-ready-charts/56515/daily0.7https://practicaldermatology.com/series/dermwire-tv/dwtv-extra-image-guided-srt-consensus/35744/daily0.7